Merck & Company (MRK) 63.24 $MRK The 7th Annual

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Merck & Company (MRK) 63.24 $MRK

The 7th Annual AscendNAAMBA Conference & Career Exposition to Take Place at New York Hilton Midtown, September 9-10, 2016
PRWeb - Tue Sep 06, 9:03AM CDT
AscendNAAMBA (National Association of Asian MBAs), Ascend's national non-profit organization for MBA/graduate students and professionals, is hosting its 7th Annual AscendNAAMBA Conference & Career Exposition at New York Hilton Midtown, September 9-10, 2016.
MRK: 63.24 (+0.26)

Merck Stops Development of Odanacatib for Osteoporosis
Zacks Equity Research - Zacks Investment Research - Mon Sep 05, 6:35AM CDT
Merck & Co., Inc. (MRK) announced that it is discontinuing the clinical development of its osteoporosis investigational therapy, odanacatib as its overall benefit-risk profile does not support filing or further development.
ANIP: 61.55 (+1.69), GERN: 3.02 (+0.27), MRK: 63.24 (+0.26), ANIK: 48.34 (+0.45)

Pharma Stock Roundup: Mylan EpiPen Pricing in Focus, FDA Nod For Novartis Biosimilar
Arpita Dutt - Zacks Investment Research - Fri Sep 02, 8:17AM CDT
Drug pricing is back in focus with lawmakers questioning Mylan's (MYL) pricing policy for EpiPen.
MRK: 63.24 (+0.26), MYL: 40.40 (+0.43), TEVA: 51.33 (+0.11), BMY: 56.96 (+0.61), NVS: 80.15 (+0.77)

Merck Provides Update on Odanacatib Development Program
BusinessWire - Fri Sep 02, 6:00AM CDT
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that it is discontinuing the development of odanacatib, Merck's investigational cathepsin K inhibitor for osteoporosis, and will not seek regulatory approval for its use. Merck previously reported a numeric imbalance in adjudicated stroke events in the pivotal Phase 3 fracture outcomes study in postmenopausal women. The company has decided to discontinue development after an independent adjudication and analysis of major adverse cardiovascular events confirmed an increased risk of stroke. The data from the analysis will be presented at the American Society for Bone Mineral Research (ASBMR) in September.
MRK: 63.24 (+0.26)

Global DNA Gyrase Subunit B (EC 5.99.1.3) Pipeline Review 2016 Featuring Abgentis, AstraZeneca, Daiichi Sankyo Company & Merck & Co. - Research and Markets
BusinessWire - Wed Aug 31, 7:43AM CDT
Research and Markets has announced the addition of the "DNA Gyrase Subunit B (EC 5.99.1.3) - Pipeline Review, H1 2016" report to their offering.
MRK: 63.24 (+0.26)

Research and Markets - Global Billion Diabetes and Obesity Drugs Market 2016-2022 with Novo Nordisk, Eli Lilly, Sanofi, Merck & Co, AstraZeneca & Takeda Dominating the $150+ Billion Market
PR Newswire Europe - Wed Aug 31, 6:10AM CDT
DUBLIN, August 31, 2016 /PRNewswire/ --
MRK: 63.24 (+0.26), LLY: 78.51 (+1.66)

Global Billion Diabetes and Obesity Drugs Market 2016-2022 with Novo Nordisk, Eli Lilly, Sanofi, Merck & Co, AstraZeneca & Takeda Dominating
GlobeNewswire - Wed Aug 31, 3:16AM CDT
Research and Markets has announced the addition of the "Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment" report to their offering.
MRK: 63.24 (+0.26), LLY: 78.51 (+1.66)

Shares of MRK Up 20.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Aug 30, 1:30AM CDT
SmarTrend identified an Uptrend for Merck (NYSE:MRK) on March 7th, 2016 at $52.34. In approximately 6 months, Merck has returned 20.39% as of today's recent price of $63.01.
MRK: 63.24 (+0.26)

Blog Coverage Consumer and Political Pressure Forces Mylan to Lower Cost of Epipen
ACCESSWIRE - Fri Aug 26, 8:19AM CDT
LONDON, UK / ACCESSWIRE / August 26, 2016 / Active Wall St. blog coverage looks at the headline from Mylan N.V. (NASDAQ: MYL). The company which has been facing tremendous public criticism and political backlash over the price increase for its product EpiPen announced on August, 25, 2016, that it is taking immediate action to enhance access by expanding existing programs to reach out to patients. Register with us now for your free membership and blog access at: http://www.activewallst.com/register/
MRK: 63.24 (+0.26), MYL: 40.40 (+0.43)

Increasing R&D investments in Therapeutic Vaccines Market - Merck and GSK Have Interesting Pipelines
PR Newswire Europe - Fri Aug 26, 7:31AM CDT
HYDERABAD, India, August 26, 2016 /PRNewswire/ --
MRK: 63.24 (+0.26)

Global Malignant Melanoma Market With Focus on Nevisense System: 2015-2020 Featuring Bristol-Myers Squibb, Merck & Co & Navidea Biopharmaceuticals - Research and Markets
BusinessWire - Thu Aug 25, 12:55PM CDT
Research and Markets has announced the addition of the "Global Malignant Melanoma Market With Focus on Nevisense System: 2015-2020" report to their offering.
NAVB: 0.80 (+0.46), MRK: 63.24 (+0.26), BMY: 56.96 (+0.61)

Sponsor and CRO Finalists Announced for Annual Society for Clinical Research Sites' Eagle Award
PR Newswire - Thu Aug 25, 9:00AM CDT
The Society for Clinical Research Sites announces today the finalists for the 2016 SCRS Eagle Award(TM). The finalists were selected from nominations provided by SCRS members. Qualifying nominees were in the 75th percentile or higher of the total nominations submitted for the Eagle Award. Voting is now open to all clinical research site professionals, regardless of their membership with SCRS, and closes September 21, 2016. Go to this website to vote.
NVO: 46.00 (+0.20), MRK: 63.24 (+0.26), AMGN: 170.84 (+1.07), LLY: 78.51 (+1.66), GSK: 43.99 (-0.27)

Biothera Pharmaceuticals Expands Relationship with Merck, Enters Collaboration for Combination Cancer Immunotherapy Trials in Multiple Indications
BusinessWire - Wed Aug 24, 10:25AM CDT
--Under previous agreement, Big Ten Cancer Research Consortium (BTCRC) plans to initiate a Phase 1b/2 Imprime PGG/KEYTRUDA trial in patients with non-small cell lung cancer (NSCLC)
MRK: 63.24 (+0.26)

Research and Markets - Prophylactic Human Vaccines Market, 2022: Global Strategic Business Report 2016 - Leading Players are GlaxoSmithKline, Merck, Pfizer and Sanofi
PR Newswire Europe - Wed Aug 24, 7:11AM CDT
DUBLIN, August 24, 2016 /PRNewswire/ --
MRK: 63.24 (+0.26)

Welly Merck Announces the Launch of Their Swiss-Designed, Modern Fashion Watch Collection That Breaks Down Cost Barriers Between Makers and Consumers
PR Newswire - Tue Aug 23, 1:54PM CDT
Welly Merck, a boutique watch maker, announces the launch of their stunning new line of timepieces. Building on long family heritages in watchmaking and steel fabrication, Welly Merck represents a modern union of quality and fashion that makes luxury watches affordable for anyone.
MRK: 63.24 (+0.26)

Veterinary Vaccines Market is Expected to Rise to US$11,403.6 mn by 2024; Rising Expenditure on Animal Healthcare by Pet Owners and Livestock Farmers to Drive Market Globally, Reports TMR
PR Newswire Europe - Tue Aug 23, 6:31AM CDT
ALBANY, New York, August 23, 2016 /PRNewswire/ --
ZTS: 51.29 (+0.03), MRK: 63.24 (+0.26)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tragedy Highlights Need for E-bike Safety Overhaul

Updated Category News Views 6

A Dire Wake-Up Call in the East Village We're staring hard at a heartbreaking mess in the East Village. A 15-year-old girl lost her life while riding an electric Citi Bike, hit by an industrial truck. Let's not dance around it—this is a gut punch, the kind you never want to ever hear about, and one that comes with a bitter flavor of 'what if?' Age Verification: A...

Continue Reading
Flying Car Regulatory Sandbox Begins in UAE

Updated Category News Views 9

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Continue Reading
Why Liver Nurture Taps into Health Sector Trends

Updated Category News Views 5

Liver Wellness: A Sector on the Rise Remember when everyone was all about heart health and cholesterol levels? Seems like these days, folks have shifted their focus a bit south—right to the liver. It's no surprise, really. With our modern diet and lifestyle choices squeezing the life out of this hard-working organ, people are on the hunt for ways to give it the TLC it...

Continue Reading
Papa John's Faces Class Action Over Misleading Info

Updated Category News Views 5

Trouble Brewing for Papa John's Investors Rolling the dice in the stock market sometimes feels like playing the lottery, doesn't it? This time around, it's Papa John's (NASDAQ: PZZA) serving up a slice of turmoil for its investors. The pizza chain's got itself tangled in a class-action lawsuit, and it's the shareholders who're left with a bitter taste. Investors Cry Foul...

Continue Reading
BarrelPick.com Launches for Bourbon Aficionados

Updated Category News Views 4

Just when you think you've seen all the ways to enjoy bourbon, along comes BarrelPick.com with a tantalizing new proposition. They're throwing down the gauntlet for bourbon lovers everywhere by letting you buy an entire barrel, let it sit around for a bit, watch it mature, and then call the shots on when it finally sees the light of day in a bottle. Talk about skipping...

Continue Reading
Med Spa Visits: Key Insights from Lindsey Smith

Updated Category News Views 4

Moving Beyond the Fear Factor Stepping into a med spa for the first time can be nerve-wracking, especially if you're unsure of what to expect. Lindsey Smith, an expert from Flawless Med Spa in Bryant, Arkansas, knows just how critical it is to navigate this terrain with clarity. Her approach emphasizes building a foundation of trust and understanding from the get-go. Fear...

Continue Reading
Qatar Foundation Spurs Sport-Driven Empowerment Moves

Updated Category News Views 4

Here we go, diving into the serious talk of the moment: sports pushing boundaries to uplift society's underdogs. Envision yourself in the halls of Wilton Park, where the thinkers, the dreamers, and the doers convened in the name of change. Qatar Foundation ain't just sitting pretty; they're championing the cause to harness sport for impactful social threads across the...

Continue Reading
USPS Rolls Out Christmas Cookie Stamps Nationwide

Updated Category News Views 5

USPS Delivers Nostalgia with Cookie-Themed Stamps Let's talk stamps, folks. The U.S. Postal Service has rolled out its newest Christmas Cookies Forever stamps, bringing a dash of sugary nostalgia to mailboxes nationwide. The release was celebrated at the Smithsonian National Postal Museum, spotlighting a tradition as sweet as the sugar cookies themselves. These aren't...

Continue Reading
Insta360 Expands with Times Square Flagship Store

Updated Category News Views 7

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...

Continue Reading

Top 5 Most Recently Viewed Articles

Luxfer Holdings Q4 Earnings: A Mixed Bag for Investors

Updated Category News Views 198

The Earnings Rollercoaster Brace yourself—Luxfer Holdings just dropped their Q4 earnings numbers, and it’s a whirlwind of good and not-so-good news. First off, the company beat EPS estimates by a jaw-dropping 21.74%, landing at $0.28 when the street was only expecting $0.23. That’s a solid performance that would normally send stocks soaring, but here we are in the...

Continue Reading
Transforming Business Decisions with SAS Decision Builder

Updated Category News Views 162

SAS Decision Builder Enhances Decision Intelligence on Microsoft Fabric SAS Decision Builder empowers organizations to leverage their data through AI-driven insights and actions that integrate seamlessly into the Microsoft Fabric ecosystem. This cloud-based solution allows businesses to harness the full potential of their data by streamlining the decision-making process....

Continue Reading
Experts Reflect on Economic Impact of Trump's Strategies

Updated Category News Views 199

Reassessing Trump's Economic Policies Amidst changing economic landscapes, several prominent economists, including former advisers to past U.S. presidents, are reevaluating the implications of President-elect Donald Trump's proposed economic measures. Their emerging consensus suggests that Trump's intention to implement broad tariffs, cut taxes, and tighten immigration...

Continue Reading
Quantum Computing Inc. Scores Major Contracts with Industry Giants

Updated Category News Views 182

Quantum Computing Inc. Expands Its Horizons Quantum Computing Inc. QUBT is making waves in the tech industry. By turning complex quantum theories into tangible technologies, the company has secured impressive contracts with a leading U.S. bank, a well-known global automaker, and NASA. This marks a significant leap from theoretical research to practical applications,...

Continue Reading
Compass CEO Robert Reffkin to Address Zelman Housing Summit

Updated Category News Views 226

Compass at the Zelman Housing Summit Compass, Inc. (NYSE: COMP) is gearing up for an exciting event as its CEO and Founder, Robert Reffkin, prepares to speak at the esteemed Zelman Housing Summit. This summit is renowned for uniting the brightest minds in residential real estate to discuss current trends and future opportunities. Insights from Robert Reffkin Robert...

Continue Reading